Agilent Technologies Inc has introduced the SureSelect DNA Capture Array, removing a major bottleneck in small-scale DNA studies by enabling scientists sequence only genomic areas of interest with next-generation sequencing (NGS) instruments. Designed for smaller studies, the SureSelect DNA Capture Arrays complement Agilent’s in-solution SureSelect Target Enrichment System, which is designed for medium to large-scale NGS studies of tens through thousands of samples, including automated high-throughput workflows.

Applied Biosystems’ ultra-high-throughput genomic analysis platform, the SOLID™ System, generates genome-wide expression profiling data at the single cell level. This can help in finding details about cell fate, accelerating the discovery of biomarkers for disease. Ability to generate such profiles of gene activity from single stem can give an idea on variation between molecules of genetically identical stem cells. Detailed characterizations of this kind give scientists a better understanding of the application of these cells in regenerative therapies for damaged cells and organs. The sensitivity of the SOLiD System, which is higher than the currently used micro-array technology, enables researchers to generate detailed gene expression profiles from the trace amounts of RNA present in single cell and cancer samples.